1. Home
  2. VHUB vs VANI Comparison

VHUB vs VANI Comparison

Compare VHUB & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VHUB

VenHub Global Inc. Common Stock

N/A

Current Price

$1.02

Market Cap

120.8M

Sector

N/A

ML Signal

N/A

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.36

Market Cap

116.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHUB
VANI
Founded
2000
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.8M
116.4M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
VHUB
VANI
Price
$1.02
$1.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
136.6K
549.9K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.92
52 Week High
$15.34
$1.92

Technical Indicators

Market Signals
Indicator
VHUB
VANI
Relative Strength Index (RSI) 43.33 57.07
Support Level $0.58 $1.17
Resistance Level $1.38 $1.55
Average True Range (ATR) 0.12 0.11
MACD -0.01 0.03
Stochastic Oscillator 41.74 47.11

Price Performance

Historical Comparison
VHUB
VANI

About VHUB VenHub Global Inc. Common Stock

Venhub Global Inc is engaged in designing and building autonomous Smart Stores that operate 24/7 without on-site staff. Each store combines robotic automation, real-time inventory tracking, and mobile-based checkout to provide secure, convenient retail access, and is offered as an integrated retail solution to store operators.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

Share on Social Networks: